Last mentioned: Mar 24, 2026
Data Stabilization
National reports confirm abortion rates remain steady despite ongoing state restrictions.
SCOTUS Ruling
Supreme Court dismisses challenge to mifepristone access on standing grounds, preserving status quo.
Supreme Court Ruling
SCOTUS maintains access to mifepristone by dismissing a challenge to FDA's rules on procedural grounds.
Retail Pharmacy Entry
Major chains CVS and Walgreens receive certification to dispense abortion pills.
Retail Launch
CVS and Walgreens begin dispensing abortion pills in select states.
Pharmacy Certification
FDA updates REMS to allow retail pharmacies to dispense mifepristone upon certification.
FDA Rule Change
FDA officially allows retail pharmacies to dispense mifepristone with a prescription.
Dobbs Decision
Supreme Court overturns Roe v. Wade, leading to state-level bans.
Dobbs Decision
U.S. Supreme Court overturns Roe v. Wade, allowing state-level bans.
Telehealth Expansion
FDA permanently removes in-person dispensing requirements, allowing mail-order access.
Mail-Order Authorization
FDA permanently removes the requirement for in-person dispensing, allowing for telehealth and mail delivery.
Protocol Expansion
FDA extends usage window to 10 weeks and reduces required office visits from three to one.
Initial FDA Approval
FDA approves Mifepristone for medical termination of early pregnancy.
Initial FDA Approval
FDA approves mifepristone for medical termination of pregnancy through seven weeks.
National data reveals that abortion rates in the United States have remained steady or increased despite a wave of state-level bans following the Dobbs decision. This trend is driven by a significant shift toward medication abortion and the rapid expansion of telehealth services protected by state shield laws.
Medication abortion now accounts for the majority of pregnancy terminations in the United States, driven by the expansion of telehealth and mail-order pharmacy access. This shift has sparked a sophisticated regulatory counter-offensive from opponents targeting FDA-approved protocols and cross-state digital health providers.
Medication abortion now accounts for the majority of pregnancy terminations in the U.S., driven by telehealth expansion and state shield laws. This shift has triggered a wave of regulatory counter-measures from opponents, focusing on the Comstock Act and FDA approval processes.
A new survey reveals that 33% of Americans are sacrificing daily necessities like food and utilities to cover rising medical expenses. This trend, amplified by viral social media narratives, highlights a deepening financial strain that threatens both consumer discretionary markets and long-term healthcare stability.
A new nationwide survey indicates that a growing number of Americans are sacrificing essential needs, including food and utility payments, to cover rising healthcare expenses. This shift in household resource allocation signals a significant 'crowd-out' effect that poses risks to consumer staples and discretionary sectors.
Seeking Alpha's post-earnings quant analysis reveals a stark divide in the healthcare sector, with innovation-driven biopharma stocks significantly outperforming retail pharmacy and managed care. The ratings highlight a shift in investor preference toward high-growth obesity and specialty medicine franchises over traditional defensive value plays.
A growing number of Americans are making drastic financial sacrifices, including skipping meals and cutting utility usage, to cover rising healthcare costs. This trend highlights a deepening affordability crisis that is reshaping consumer spending patterns and threatening long-term economic stability.
A significant shift in consumer behavior emerged in 2025 as one-third of Americans were forced to reduce spending on essential and discretionary retail categories to afford rising healthcare costs. This trend highlights a growing 'healthcare tax' on the household wallet that is directly cannibalizing growth in the e-commerce and traditional retail sectors.
US healthcare payers and providers are escalating a long-standing financial conflict by deploying sophisticated AI tools to automate claim denials and payment appeals. This technological arms race is reshaping revenue cycle management and drawing intense regulatory scrutiny over the transparency of algorithmic decision-making.
Millions of Americans are making extreme financial trade-offs, including skipping meals and cutting utilities, to afford rising healthcare costs. This systemic affordability crisis poses significant risks to consumer spending and the long-term sustainability of the healthcare sector.
Revlon has appointed Mario Rivera as its new Chief Operating Officer, charging him with a comprehensive end-to-end transformation of the company’s global supply chain. Rivera joins the cosmetics giant following significant leadership roles at CVS Health and Target, bringing deep retail and pharmacy logistics expertise to the legacy brand.